methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate

Methyl N-{[(1R)-1-( { 1-[ (benzyloxy ) carbon yl ] -L-prolyl -6-ammonio -L-norleuc yl } amino ) – 2 – phenyleth yl ] ( hydro xy ) phosph ory l } – L-alanyl – L-prolin ate is a synthetic peptide-based small molecule, primarily studied as an experimental compound. It is not approved for clinical use and has no known marketed indications. The compound features a complex structure with multiple amino acid residues and a phosphorylated moiety, suggesting it may have been designed as an enzyme inhibitor or for biochemical research purposes. Its mechanism of action, pharmacological targets, and therapeutic applications are not established in the literature[2][3][7].

Other names

Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome((5S)-6-(((1R)-1-(hydroxy-(((2S)-1-((2S)-2-methoxycarbonylpyrrolidin-1-yl)-1-oxopropan-2-yl)amino)phosphoryl)-2-phenylethyl)amino)-6-oxo–5–(((2S)–1–phenylmethoxycarbonylpyrrolidine–2-carbonyl)amino)hexyl)azanium